Wednesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com Biotechnology INTL STEM CELL CORP +18.11% OBAGI MEDICAL +13.83% NABI BIOPHARMACEUT +11.28% ZIOPHARM ONCOLOGY IN +11.11% HESKA CORPORATION +10.80% Diagnostic Substances NYMOX PHARM CORP +8.13% IMMUCOR INC +5.96% GENE LOGIC INC +5.26% INTERLEUKIN GENETICS +4.89% SYNTA…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
by H.S. Ayoub
BioHealth Investor.com
Biotechnology
INTL STEM CELL CORP [ISCO.OB] +18.11%
OBAGI MEDICAL [OMPI] +13.83%
NABI BIOPHARMACEUT [NABI] +11.28%
ZIOPHARM ONCOLOGY IN [ZIOP] +11.11%
HESKA CORPORATION [HSKA] +10.80%
Diagnostic Substances
NYMOX PHARM CORP [NYMX] +8.13%
IMMUCOR INC [BLUD] +5.96%
GENE LOGIC INC [GLGC] +5.26%
INTERLEUKIN GENETICS [ILI] +4.89%
SYNTA PHARMACEUTICAL [SNTA]
Drug Delivery
EMISPHERE TECH [EMIS] +5.54%
NOVADEL PHARMA INC [NVD] +4.75%
SKYEPHARMA PLC [SKYE] +4.09%
NOVEN PHARMACEUTIC [NOVN] +3.48%
COLUMBIA LABS INC [CBRX] +3.40%
Drug Manufacturers
PAIN THERAPEUTICS [PTIE] +14.90%
JAVELIN PHARMACEUTIC [JAV] +13.20%
ANGIOTECH PHARMA I [ANPI] +12.78%
PROVECTUS PHARMA [PVCT.OB] +8.39%
NOVO NORDISK A S [NVO] +6.66%
Drug Related Products
XELR8 HOLDINGS, INC [BZI] +11.06%
SALIX PHARM DEL [SLXP] +3.25%
PACIFICHEALTH LABS [PHLI.OB] +3.09%
TIENS BIOTECH GR USA [TBV] +2.69%
N B T Y INC [NTY] +1.69%
Generic Drugs
WATSON PHARMACEUTCLS [WPI] +4.00%
ISOLAGEN INC [ILE] +3.78%
BARR PHARMA INC [BRL] +2.63%
CARACO PHARMA LABS [CPD] +1.54%
MYLAN LABS INC [MYL] +0.90%
Medical Appliances & Equipment
FONAR CORP NEW [FONRD] +11.41%
NON INVASIVE MONITORNG SYS NEW [NIMU.OB] +11.25%
SPAN AMERICA MED S [SPAN] +10.36%
ACCURAY INCORPORATED [ARAY] +10.25%
CRYOLIFE INC [CRY] +8.50%
Medical Instruments & Supplies
APA ENTERPRISES [APAT] +24.37%
IMPLANT SCIENCES CP [IMX] +9.50%
HEMOSENSE INC. [HEM] +9.48%
HAEMONETICS CP [HAE] +9.33%
MERIT MEDICAL SYS [MMSI] +6.02%
Medical Laboratories & Research
NATL DENTEX CP [NADX] +8.35%
AETERNA ZENTARIS [AEZS] +4.97%
NEOGENOMICS INC [NGNM.OB] +4.38%
ENZO BIOCHEM INC [ENZ] +3.46% $
ERESEARCHTECHNOLOG [ERES] +1.96%
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.